Sun Young Choi
Ewha Womans University
6 Papers
2 Citations
Sun Young Choi is an academic researcher from Ewha Womans University. The author has contributed to research in topics: Deep vein & Thrombosis. The author has an hindex of 3, co-authored 6 publications.
Chat about Author
Papers
Diagnosis and Treatment of Lower Extremity Deep Vein Thrombosis: Korean Practice Guidelines.
Seung-Kee Min,Young Hwan Kim,Jin Hyun Joh,Jin Mo Kang,Ui Jun Park,Hyung-Kee Kim,Jeong-Hwan Chang,Sang Jun Park,Jang Yong Kim,Jae Ik Bae,Sun Young Choi,Chang Won Kim,Sung Il Park,Nam Yeol Yim,Yong Sun Jeon,Hyun-Ki Yoon,Ki Hyuk Park +16 more
TL;DR: This work intends to provide evidence-based guidelines for diagnosis and treatment of lower extremity deep vein thrombosis by multidisciplinary consensus and are the result of a close collaboration between interventional radiologists and vascular surgeons.
56
Diagnosis and Treatment of Lower Extremity Deep Vein Thrombosis: Korean Practice Guidelines
Young Hwan Kim,Seung-Kee Min,Jin Mo Kang,Hyung-Kee Kim,Jae Ik Bae,Sun Young Choi,Sang Jun Park,Jeong-Hwan Chang,Ui Jun Park,Chang Won Kim,Sung Il Park,Jang Yong Kim,Nam Yeol Yim,Yong Sun Jeon,Jin Hyun Joh,Ki Hyuk Park,Hyun-Ki Yoon +16 more
TL;DR: This work intends to provide evidence-based guidelines for diagnosis and treatment of lower extremity deep vein thrombosis by multidisciplinary consensus and are the result of a close collaboration between interventional radiologists and vascular surgeons.
43
Evaluation of sclerotherapy for the treatment of infected postoperative lymphocele
TL;DR: Sclerotherapy significantly reduces the drainage volume, and might help shorten catheter placement time in infected lymphoceles in gynecologic malignancy patients.
15
Endovascular Intervention as Management for Acute Limb Ischemia, Including the Rutherford Class IIb Ischemia: Korean Experience
TL;DR: Endovascular Intervention as Management for Acute Limb ischemia, Including the Rutherford Class IIb Ischemia: Korean Experience reports no difference in limb salvage or death after ≥ 30-day follow-up, but a higher incidence of major complications, such as hemorrhage, stroke, and distal embolization in patients treated with thrombosis.